199 related articles for article (PubMed ID: 19651509)
1. Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors.
González A; Quirante J; Nieto J; Almeida MR; Saraiva MJ; Planas A; Arsequell G; Valencia G
Bioorg Med Chem Lett; 2009 Sep; 19(17):5270-3. PubMed ID: 19651509
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Green NS; Palaninathan SK; Sacchettini JC; Kelly JW
J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design.
Cardoso I; Almeida MR; Ferreira N; Arsequell G; Valencia G; Saraiva MJ
Biochem J; 2007 Nov; 408(1):131-8. PubMed ID: 17683281
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state.
Petrassi HM; Johnson SM; Purkey HE; Chiang KP; Walkup T; Jiang X; Powers ET; Kelly JW
J Am Chem Soc; 2005 May; 127(18):6662-71. PubMed ID: 15869287
[TBL] [Abstract][Full Text] [Related]
5. Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.
Johnson SM; Petrassi HM; Palaninathan SK; Mohamedmohaideen NN; Purkey HE; Nichols C; Chiang KP; Walkup T; Sacchettini JC; Sharpless KB; Kelly JW
J Med Chem; 2005 Mar; 48(5):1576-87. PubMed ID: 15743199
[TBL] [Abstract][Full Text] [Related]
6. Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
Dolado I; Nieto J; Saraiva MJ; Arsequell G; Valencia G; Planas A
J Comb Chem; 2005; 7(2):246-52. PubMed ID: 15762752
[TBL] [Abstract][Full Text] [Related]
7. Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties.
Sriram D; Bal TR; Yogeeswari P
J Pharm Pharm Sci; 2005 Oct; 8(3):565-77. PubMed ID: 16401403
[TBL] [Abstract][Full Text] [Related]
8. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW
J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308
[TBL] [Abstract][Full Text] [Related]
9. Amyloid disease prevention by transthyretin native state complexation with carborane derivatives lacking cyclooxygenase inhibition.
Julius RL; Hawthorne MF
Drug News Perspect; 2008 Jun; 21(5):258-66. PubMed ID: 18596990
[TBL] [Abstract][Full Text] [Related]
10. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M
J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769
[TBL] [Abstract][Full Text] [Related]
12. Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
Wiseman RL; Green NS; Kelly JW
Biochemistry; 2005 Jun; 44(25):9265-74. PubMed ID: 15966751
[TBL] [Abstract][Full Text] [Related]
13. Chemical synthesis, in vitro acetohydroxyacid synthase (AHAS) inhibition, herbicidal activity, and computational studies of isatin derivatives.
Wang J; Tan H; Li Y; Ma Y; Li Z; Guddat LW
J Agric Food Chem; 2011 Sep; 59(18):9892-900. PubMed ID: 21838297
[TBL] [Abstract][Full Text] [Related]
14. 6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.
Diaz P; Phatak SS; Xu J; Astruc-Diaz F; Cavasotto CN; Naguib M
J Med Chem; 2009 Jan; 52(2):433-44. PubMed ID: 19115816
[TBL] [Abstract][Full Text] [Related]
15. Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.
Gupta S; Chhibber M; Sinha S; Surolia A
J Med Chem; 2007 Nov; 50(23):5589-99. PubMed ID: 17948976
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, and biological evaluation of isatin derivatives as potential glycosyltransferase inhibitors.
Wang Y; Chan FY; Sun N; Lui HK; So PK; Yan SC; Chan KF; Chiou J; Chen S; Abagyan R; Leung YC; Wong KY
Chem Biol Drug Des; 2014 Dec; 84(6):685-96. PubMed ID: 24890564
[TBL] [Abstract][Full Text] [Related]
17. QSAR study of isatin analogues as in vitro anti-cancer agents.
Sabet R; Mohammadpour M; Sadeghi A; Fassihi A
Eur J Med Chem; 2010 Mar; 45(3):1113-8. PubMed ID: 20056518
[TBL] [Abstract][Full Text] [Related]
18. Sedative-hypnotic profile of novel isatin ketals.
Zapata-Sudo G; Pontes LB; Gabriel D; Mendes TC; Ribeiro NM; Pinto AC; Trachez MM; Sudo RT
Pharmacol Biochem Behav; 2007 Apr; 86(4):678-85. PubMed ID: 17382995
[TBL] [Abstract][Full Text] [Related]
19. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of anti-HIV activity of isatin beta-thiosemicarbazone derivatives.
Bal TR; Anand B; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2005 Oct; 15(20):4451-5. PubMed ID: 16115762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
